Sign Up | Log In | What is SocialPicks?

Alexza Pharmaceuticals Inc. (ALXA) Trade Now » Rate ALXA - Discuss ALXA - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

92.5%

Top:

100.0%

Rate ALXA:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

ALXA Analysis & Videos »

... View All >

ALXA: Bull or Bear?

Trading FDA, Clinical Trial Binary Events: $AFFY $ALXA $INCY $PGNX ALXA

73%

+82.80%
in 1048 days

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news... <> <font> Affymax (NASDAQ:AFFY) and partner Takeda Pharma (OTC:TKPHY) reported that further analysis is ongoing for the previously reported pivotal PEARL and EMERALD studies of HEMATIDE (long-acting anemia drug) (peg-inesatide) for the treatment of chronic renal failure patients with anemia. The companies expect to discuss a potential registration strategy with the FDA by year-end 2010, which could lead to a New Drug Application (NDA) filing that seeks marketing clearance for t...

Continue reading »

By Mike Havrilla (+1.04% risk: moderate) 08/05/10

110 comments

ALEXZA PHARMACEUTICALS INC : SCHIZOPHRENIA KIND OF STOCK ALXA

N/A

-10.06%
in 98 days
(closed on 09/17/10)

Most biotechs are losing money sometimes for decades and all of them promise some wonderful pill, very often such promises turn out to be empty. The only losers are investors who bought such a stock because for biotech company employees and insiders it's a business as usual, they get paid, bonuses, options, benefits, golden parachutes, free stock. I don't want to change the world of biotechnology sector, all I want is to make money by selling ( ALXA ) stock short and walk away without getting bipolar disorder in the meantime by reading all the wonderful news, key developments and ...

Continue reading »

By PAUL& SHARK (-13.59% risk: conservative) 06/11/10

25 comments

Alexza Pharma Outlook Cautious ALXA

+8.04%
in 1830 days

The stock took a big hit after the failure of AZ-002 candidate for panic attacks associated with panic disorder.

Continue reading »

By Zacks.com (-1.03% risk: moderate) 06/13/08

1 comment

... View All >

People Bullish on ALXA

Mike Havrilla

Principal

73%

over 2 years ago

fotsirko

Analyst

N/A

over 3 years ago

mattoruu

Analyst

N/A

over 3 years ago

Bio RunUp

Analyst

N/A

over 3 years ago

Roomy Naqvy

Associate

39%

over 5 years ago

People Bearish on ALXA

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+32.13%	538
2	Gerald Greene	18.14	+6.82%	289
3	stockmarketfunding.com	17.66	+22.47%	85
4	akiralegrand	13.47	+13.86%	71
5	anup2104	12.13	+175.56%	106

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
GLD	streetTRACKS Gold
RIG	Transocean Inc
MO	Altria Group Inc
RIMM	Research in Motion Ltd
POT	Potash Corp. of Saskatchewan Inc.
DELL	Dell Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

Stop Waiting for the Crash; Use a Regular Investment Plan
by Dan Caplinger (Fool.com) about SPY DJI

... more »

TODAY'S TOP PICKS

PHG		Koninklijke Philips N.V. - Value Alert by Wax Ink
KNL		Knoll, Inc. - Value Alert by Wax Ink
JAZZ		Jazz Pharmaceuticals Inc. (JAZZ) Over +10000% in 30 month - take ... by Yannis Maarten
ORCL		Oracle Corp (ORCL) - Problems with Java don´t take an end $ 28 pos... by Yannis Maarten
JBL		Jabil Circuit Inc. (JBL) - unbelievably overestimates $ 10.00 poss... by Yannis Maarten

... more »

StreetInsider.com on ALXA

Video Interview: Thomas B. King, President and Chief Executive Officer, Alexza Pharmaceuticals, Inc. [ALXA]

Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference

Alexza Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011

Form 8-K Alexza Pharmaceuticals For: Aug 19

Alexza Pharma (ALXA) Reports FDA Accepts ADASUVE NDA as Class 2 Response to Letter

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Alexza Pharmaceuticals Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.